Related Experiment Video
Updated: Jun 28, 2025

05:25
Author Spotlight: Assessing Brain Activity in Robotic-Assisted Lower Limb Rehabilitation Using fNIRS
Published on: June 7, 2024
1.2K
Mobility Rates After Lower-Limb Amputation for Patients Treated with Physician-Led Collaborative Care Model
Allison McGinnis1, Zach Weber1, Bara Zuhaili2
1Amputee Associates, LLC, Nashville, TN.
Annals of Vascular Surgery
|April 10, 2024
Summary
A physician-led collaborative care pathway improved prosthetic mobility for 62.2% of major lower-limb amputation patients. This approach, particularly effective for transtibial amputations, shows promise for better patient outcomes.
Area of Science:
- Vascular Surgery
- Amputation Management
- Prosthetic Rehabilitation
Background:
- Historically poor clinical outcomes and disorganized care for major lower-limb amputations.
- Need for physician-led, structured care pathways for patients with chronic limb-threatening ischemia and/or diabetes.
Purpose of the Study:
- To examine postamputation prosthetic mobility rates in patients treated under a physician-led collaborative care pathway.
- To describe the structure and utilization of this pathway across multiple US vascular surgery practices.
Main Methods:
- Retrospective review of 2,475 patient records from 6 vascular practices (2017-2020).
- Inclusion criteria: documented amputation surgery, prosthetic services, and mobility status.
- Analysis focused on 1,787 eligible patients undergoing 2,157 major lower-limb amputations.
Main Results:
- 62.2% of patients achieved mobility with the collaborative care pathway.
- Mobility rates varied by amputation level: 73.5% (transtibial), 40.4% (transfemoral), 35.7% (through-knee).
- Achieved mobility rates are superior or equivalent to published benchmarks.
Conclusions:
- The physician-led collaborative care pathway aligns with key global guidelines for chronic limb-threatening ischemia.
- The pathway shows potential for improving prosthetic mobility post-amputation.
- Further evaluation is recommended to confirm impact on mobility and other clinical outcomes.

